DES-GAMMA CARBOXY PROTHROMBIN DCPPIVKA II SERUM Test
About the Test
The DES-Gamma Carboxy Prothrombin (DCP) /PIVKA II Serum test is a blood test used to detect the presence of abnormal forms of prothrombin in the blood. Prothrombin is a protein produced by the liver that plays a crucial role in blood clotting.
In certain conditions, such as liver cancer or liver cirrhosis, the liver may produce abnormal forms of prothrombin known as DCP or PIVKA II. These abnormal forms of prothrombin are not fully functional and can lead to an increased risk of bleeding or abnormal blood clotting.
The DCP/PIVKA II Serum test measures the levels of DCP or PIVKA II in the blood, indicating the presence of liver disease or liver cancer. It is often used as a tumor marker for hepatocellular carcinoma (HCC), which is the most common type of liver cancer.
Test Details
- Test Name: DES-GAMMA CARBOXY PROTHROMBIN DCPPIVKA II SERUM Test
- Components: Chemiluminescent Microparticle Immunoassay
- Price: 820.0 AED
- Sample Condition: 2 mL (0.5 mL min.) serum from 1 SST. Ship refrigerated or frozen. Give brief clinical history.
- Report Delivery: Sample Mon by 9 am; Report Same day
- Test Type: Cancer
- Doctor: Oncologist, Gastroenterologist
- Test Department: IMMUNOASSAY
- Pre Test Information: Give brief clinical history.
Symptoms and Diagnosis
The DES-Gamma Carboxy Prothrombin (DCP) /PIVKA II Serum test is typically ordered if a person has risk factors for liver disease or liver cancer, such as chronic hepatitis B or C infection, alcohol abuse, or a family history of liver cancer. It can also be used to monitor the effectiveness of treatment for liver cancer or to detect its recurrence.
Results of the test are usually reported as a numerical value, with higher values indicating a higher risk of liver disease or liver cancer. However, it is important to note that while the DCP/PIVKA II Serum test is a useful tool in the diagnosis and monitoring of liver disease and liver cancer, it is not specific to these conditions. Elevated levels of DCP or PIVKA II can also be seen in other conditions, such as vitamin K deficiency or disseminated intravascular coagulation (DIC). Therefore, the test results should always be interpreted in conjunction with other clinical and laboratory findings.
Conclusion
The DES-Gamma Carboxy Prothrombin (DCP) /PIVKA II Serum test offered by DNA Labs UAE is an important tool in the diagnosis and monitoring of liver disease and liver cancer. It helps detect the presence of abnormal forms of prothrombin in the blood, indicating the risk of liver disease or liver cancer. If you have risk factors for liver disease or liver cancer, consult with an Oncologist or Gastroenterologist to determine if this test is right for you.
| Test Name | DES-GAMMA CARBOXY PROTHROMBIN DCPPIVKA II SERUM Test |
|---|---|
| Components | |
| Price | 820.0 AED |
| Sample Condition | 2 mL (0.5 mL min.) serum from 1 SST. Ship refrigerated or frozen. Give brief clinical history. |
| Report Delivery | Sample Mon by 9 am; Report Same day |
| Method | Chemiluminescent Microparticle Immunoassay |
| Test type | Cancer |
| Doctor | Oncologist, Gastroenterologist |
| Test Department: | IMMUNOASSAY |
| Pre Test Information | Give brief clinical history. |
| Test Details | The DES-Gamma Carboxy Prothrombin (DCP) /PIVKA II Serum test is a blood test used to detect the presence of abnormal forms of prothrombin in the blood. Prothrombin is a protein produced by the liver that plays a crucial role in blood clotting. In certain conditions, such as liver cancer or liver cirrhosis, the liver may produce abnormal forms of prothrombin known as DCP or PIVKA II. These abnormal forms of prothrombin are not fully functional and can lead to an increased risk of bleeding or abnormal blood clotting. The DCP/PIVKA II Serum test measures the levels of DCP or PIVKA II in the blood, indicating the presence of liver disease or liver cancer. It is often used as a tumor marker for hepatocellular carcinoma (HCC), which is the most common type of liver cancer. The test is typically ordered if a person has risk factors for liver disease or liver cancer, such as chronic hepatitis B or C infection, alcohol abuse, or a family history of liver cancer. It can also be used to monitor the effectiveness of treatment for liver cancer or to detect its recurrence. The DCP/PIVKA II Serum test is performed by drawing a blood sample from a vein in the arm. The sample is then sent to a laboratory for analysis. Results are usually reported as a numerical value, with higher values indicating a higher risk of liver disease or liver cancer. It is important to note that while the DCP/PIVKA II Serum test is a useful tool in the diagnosis and monitoring of liver disease and liver cancer, it is not specific to these conditions. Elevated levels of DCP or PIVKA II can also be seen in other conditions, such as vitamin K deficiency or disseminated intravascular coagulation (DIC). Therefore, the test results should always be interpreted in conjunction with other clinical and laboratory findings. |
